Bain Capital Acquires Majority Stake in Milacron Injection Molding and Extrusion Business

February 5, 2025

Bain Capital’s Special Situations team agreed to purchase an approximately 51% majority stake in the Milacron injection molding and extrusion business from Hillenbrand for $287 million, with Hillenbrand retaining roughly 49% and remaining an investor. Bain will have operational control and will partner with Milacron management to accelerate growth while Hillenbrand uses proceeds to pay down debt and focus on its core portfolio.

Buyers
Bain Capital
Targets
Milacron Injection Molding and Extrusion business
Sellers
Hillenbrand, Inc.
Industry
Manufacturing
Location
Ohio, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.